Inget foto på Anna Kreutzman

Anna Kreutzman

  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

20102019
Om du gjort några ändringar i Pure kommer de visas här snart.

Publikationer 2010 2019

Filter
Artikel
Artikel

Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-alpha Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile

Kreutzman, A., Rohon, P., Faber, E., Indrak, K., Juvonen, V., Kairisto, V., Voglova, J., Sinisalo, M., Flochova, E., Vakkila, J., Arstila, P., Porkka, K. & Mustjoki, S., 2011, I : PLoS One. 6, 8, s. art. e23022 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells

Kreutzman, A., Ilander, M., Porkka, K., Vakkila, J. & Mustjoki, S., 1 maj 2014, I : OncoImmunology. 3, e28925.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner

Kreutzman, A., Colom-Fernandez, B., Marcos Jimenez, A., Ilander, M., Cuesta-Mateos, C., Perez-Garcia, Y., Delgado Arevalo, C., Bruck, O., Hakanen, H., Saarela, J., Ortega-Carrion, A., de Rosendo, A., Juanes-Garcia, A., Luis Steegmann, J., Mustjoki, S., Vicente-Manzanares, M. & Munoz-Calleja, C., 1 nov 2017, I : Clinical Cancer Research. 23, 21, s. 6697-6707 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-alpha Monotherapy

Ilander, M., Kreutzman, A., Rohon, P., Melo, T., Faber, E., Porkka, K., Vakkila, J. & Mustjoki, S., 31 jan 2014, I : PLoS One. 9, 1, 11 s., 87794.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Expansion of highly differentiated CD8(+) T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Kreutzman, A., Ladell, K., Koechel, C., Gostick, E., Ekblom, M., Stenke, L., Melo, T., Einsele, H., Porkka, K., Price, D. A., Mustjoki, S. & Seggewiss, R., 2011, I : Leukemia. 25, s. 1587-1597 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Imatinib and pegylated IFN-alpha 2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response

Koskenvesa, P., Kreutzman, A., Rohon, P., Pihlman, M., Vakkila, E., Rasanen, A., Vapaatalo, M., Remes, K., Lundan, T., Hjorth-Hansen, H., Vakkila, J., Simonsson, B., Mustjoki, S. & Porkka, K., maj 2014, I : European Journal of Haematology. 92, 5, s. 413-420 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Immune cell phenotype and functional defects in Netherton syndrome

Eränkö, E., Ilander, M., Tuomiranta, M., Mäkitie, A., Lassila, T., Kreutzman, A., Klemetti, P., Mustjoki, S., Hannula-Jouppi, K. & Ranki, A., 26 nov 2018, I : Orphanet journal of rare diseases. 13, 10 s., 213.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

Kreutzman, A., Yadav, B., Brummendorf, T. H., Gjertsen, B. T., Lee, M. H., Janssen, J., Kasanen, T., Koskenvesa, P., Lotfi, K., Markevärn, B., Olsson-Stromberg, U., Stentoft, J., Stenke, L., Söderlund, S., Udby, L., Richter, J., Hjörth-Hansen, H. & Mustjoki, S., 2 sep 2019, I : OncoImmunology. 8, 9, 13 s., e1638210.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Interferon Alpha Treated Patients with Chronic Myeloid Leukemia (CML) In Prolonged Complete Remission Have Increased Numbers of NK-Cells and Clonal Gamma-Delta T-Cells, and a Distinct Plasma Cytokine Profile.

Kreutzman, A., Rohon, P., Faber, E., Indrak, K., Juvonen, V., Kairisto, V., Voglova, J., Sinisalo, M., Flochova, E., Arstila, P., Porkka, K. & Mustjoki, S., 2010, I : Blood. 116, s. 515-516 2 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

Kreutzman, A., Jaatinen, T., Greco, D., Vakkila, E., Richter, J., Ekblom, M., Hjorth-Hansen, H., Stenke, L., Melo, T., Paquette, R., Seggewiss-Bernhardt, R., Guerci-Bresler, A., Talbot, A., Cayuela, J. M., Mahon, F-X., Porkka, K., Lipton, J., Partanen, J., Rousselot, P. & Mustjoki, S., 1 nov 2012, I : Experimental Hematology. 40, 11, s. 906-913 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Kreutzman, A., Juvonen, V., Kairisto, V., Ekblom, M., Stenke, L., Seggewiss, R., Porkka, K. & Mustjoki, S., 2010, I : Blood. 116, 5, s. 772-782 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Poor cytokine-induced phosphorylation in chronic myeloid leukemia patients at diagnosis is effectively reversed by tyrosine kinase inhibitor therapy

Jalkanen, S. E., Vakkila, J., Kreutzman, A., Nieminen, J. K., Porkka, K. & Mustjoki, S., 2011, I : Experimental Hematology. 39, 1, s. 102-113 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy

Mustjoki, S., Auvinen, K., Kreutzman, A., Rousselot, P., Hernesniemi, S., Melo, T., Lahesmaa-Korpinen, A-M., Hautaniemi, S., Bouchet, S., Molimard, M., Smykla, R., Lee, F. Y., Vakkila, J., Jalkanen, S., Salmi, M. & Porkka, K., apr 2013, I : Leukemia. 27, 4, s. 914-924 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia

Koskela, H. L. M., El Missiry, M., Ruusila, A., Koskenvesa, P., Bruemmendorf, T. H., Gjertsen, B. T., Janssen, J., Lotfi, K., Markevarn, B., Olsson-Stromberg, U., Stenke, L., Stentoft, J., Richter, J., Hjorth-Hansen, H., Kreutzman, A. & Mustjoki, S., aug 2017, I : Journal of Cancer Research and Clinical Oncology. 143, 8, s. 1543-1554 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil